ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly weighted-average interest rate on short-term borrowings (%) [reported through FY2024] (%)
Form 10-K Debt Note
Latest, FY2024
4.6%
Period ended Dec 31, 2024
Change on a year earlier
-534.4 pts
539.0% in FY2023
History
8 years
Since FY2016
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Weighted-average interest rate on short-term borrowings (%) [reported through FY2024] (%) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Dec 31, 2024 | 4.6% | -534.4 pts | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 539.0% | +119.0 pts | Form 10-K (filed 2025-02-19) ↗ |
| FY2022 | Dec 31, 2022 | 420.0% | – | Form 10-K (filed 2024-02-21) ↗ |
| FY2020 | Dec 31, 2020 | 1.7% | 0.0 pts | Form 10-K (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 1.7% | -0.7 pts | Form 10-K (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 2.4% | +1.0 pts | Form 10-K (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 1.3% | +0.8 pts | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 0.6% | – | Form 10-K (filed 2017-02-21) ↗ |
Cite this data
StockData. (2026). Eli Lilly Weighted-average interest rate on short-term borrowings (%) [reported through FY2024] (%), annual FY2016–FY2024 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/st_debt_rate
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.